AUD 2.26
(-0.44%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -0.26 AUD | -336.36% |
2023 | 0.11 AUD | 57.59% |
2022 | 0.07 AUD | -56.38% |
2021 | 0.16 AUD | 33.33% |
2020 | 0.12 AUD | 20.0% |
2019 | 0.10 AUD | 33.51% |
2018 | 0.07 AUD | -31.91% |
2017 | 0.11 AUD | 33.98% |
2016 | 0.08 AUD | 163.14% |
2015 | 0.03 AUD | -33.05% |
2014 | 0.05 AUD | 5.91% |
2013 | 0.04 AUD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.29 AUD | -859.16% |
2024 Q4 | 0.03 AUD | 108.93% |
2024 FY | - AUD | -336.36% |
2023 Q2 | 0.07 AUD | 261.46% |
2023 FY | - AUD | 57.59% |
2023 Q4 | 0.04 AUD | -44.96% |
2022 Q2 | 0.05 AUD | -11.15% |
2022 FY | - AUD | -56.38% |
2022 Q4 | 0.02 AUD | -61.75% |
2021 Q2 | 0.10 AUD | 61.53% |
2021 Q4 | 0.06 AUD | -43.22% |
2021 FY | - AUD | 33.33% |
2020 FY | - AUD | 20.0% |
2020 Q4 | 0.06 AUD | 0.98% |
2020 Q2 | 0.06 AUD | -3.94% |
2019 Q4 | 0.06 AUD | -6.89% |
2019 FY | - AUD | 33.51% |
2019 Q2 | 0.07 AUD | 45.42% |
2018 Q4 | 0.05 AUD | -17.57% |
2018 Q2 | 0.06 AUD | 21.06% |
2018 FY | - AUD | -31.91% |
2017 Q4 | 0.05 AUD | -21.27% |
2017 FY | - AUD | 33.98% |
2017 Q2 | 0.06 AUD | 13.07% |
2016 Q4 | 0.05 AUD | 86.57% |
2016 Q2 | 0.03 AUD | -52.03% |
2016 FY | - AUD | 163.14% |
2015 Q4 | 0.06 AUD | 327.8% |
2015 FY | - AUD | -33.05% |
2015 Q2 | -0.03 AUD | 0.0% |
2014 FY | - AUD | 5.91% |
2013 FY | - AUD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Australian Clinical Labs Limited | 0.12 AUD | 316.667% |
BCAL Diagnostics Limited | -0.03 AUD | -900.0% |
Genetic Signatures Limited | -0.11 AUD | -136.364% |
Genetic Technologies Limited | -0.09 AUD | -186.029% |
Healius Limited | -0.98 AUD | 73.469% |
Imagion Biosystems Limited | -0.41 AUD | 36.585% |
INOVIQ Ltd | -0.07 AUD | -266.714% |
Microba Life Sciences Limited | -0.05 AUD | -434.979% |
Monash IVF Group Limited | -0.02 AUD | -1447.619% |
Rhythm Biosciences Limited | -0.03 AUD | -766.667% |
Sonic Healthcare Limited | 1.07 AUD | 124.299% |